Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 27 October 2023, 21:00 HKT/SGT

Source: EW Healthcare Partners
EW Healthcare Partners Acquires Stake in Boiron Group, a Leader in Natural Medicine

LONDON, Oct 27, 2023 - (ACN Newswire) - EW Healthcare Partners announced that it has acquired a c. 25% minority stake in Boiron Developpement, an entity formed for the purposes of launching a tender offer for the Boiron Group, in partnership with the Boiron Family, at a c. €875 million enterprise value. As part of this transaction, the Boiron family has transferred its 70% stake in the Boiron Group to Boiron Developpement, together with the Boiron employee fund for c. 5% of the capital.

Boiron is a French pharmaceutical company focused on natural medicine, founded in 1932 by pharmacists Jean and Henri Boiron. The company is built around homeopathy and has spearheaded the industry's global development.

Boiron today is the global market leader in homeopathy and a leading global player in natural medicines, with 2022 revenues of €534M. The company offers a diversified portfolio of natural, innovative, science-based, and personalized pharmaceutical products. Over 50% of Boiron's sales are realized outside of France. Boiron benefits from an integrated value chain from registration to distribution, including in-house manufacturing, with the company currently present in 50 countries globally through 23 subsidiaries and 30 distributors. Boiron has also established a strong footprint in the U.S. with €120M in U.S. revenue, with a large portion of products sold through the e-commerce channel.

EW Healthcare Partners is excited to partner with the Boiron family to help further accelerate the company's growth, by expanding the company's offering into additional healthcare verticals and capitalising on the existing platform to launch additional products, in particular in the U.S.

About EW Healthcare Partners ("EW")

With over $2 billion of capital raised since 2014, EW Healthcare Partners seeks to make growth equity investments in fast-growing commercial-stage healthcare companies in the pharmaceutical, medical device, diagnostics, and technology-enabled services sectors in the United States and in Europe. EW Healthcare Partners has a singular commitment to the healthcare industry and has been a long-term investor in numerous healthcare companies, ranging across sectors, stages and geographies. The team of senior investment professionals, operating partners and advisors is based in New York, London and Houston.

Contact Information

Anne DeMaret, Investor Relations, (281) 528-1956

Topic: Press release summary
Source: EW Healthcare Partners

Sectors: BioTech, Healthcare & Pharm
From the Asia Corporate News Network

Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

Latest Press Releases
Global Humanitarian Gurudev Sri Sri Ravi Shankar to Conduct Mental Health Masterclass in Singapore  
Feb 28, 2024 13:00 HKT/SGT
LYC Healthcare Reports Strong Q3 FY2024 Results of RM36.0 Million  
Feb 28, 2024 09:34 HKT/SGT
TechInvention Lifecare announces the ground breaking of its state-of-the-art Global Collaborative Centre for Medical Countermeasures   
Feb 28, 2024 09:00 HKT/SGT
Avance Clinical CEO Talks with SCRIP about US Biotech Sector "Green Shoots" and a New CRO Report  
Feb 28, 2024 08:00 HKT/SGT
Q2 Metals Concludes Its 2024 Winter Drill Program at the Mia Lithium Property, James Bay Territory, Quebec, Canada  
Feb 27, 2024 21:09 HKT/SGT
U.S. Polo Assn. Supports 2024 U.S. Open Women's Polo Championship(R) Airing on ESPN  
Feb 27, 2024 21:00 HKT/SGT
Tuxera Expands Collaboration With Microsoft on New SMB Licensing Solution  
Feb 27, 2024 21:00 HKT/SGT
Genetec Sets the Stage for Higher Growth Following a Strong Q3FY2024 Performance  
Feb 27, 2024 20:00 HKT/SGT
HKTDC Hong Kong International Diamond, Gem and Pearl Show opens at AsiaWorld-Expo today  
Feb 27, 2024 20:00 HKT/SGT
DOCOMO to Conduct Open RAN Field Trials with Ooredoo, Smart and StarHub  
Tuesday, February 27, 2024 6:53:00 PM
More Press release >>
More >>
 News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: